QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTC: LXRP) DehydraTECH to be Leveraged Through CBD License Agreement with Universal Hemp
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTC: LXRP) today announced its entry into a definitive…